Role Of Colposcopy In Evaluation Of Suspicious Cervix

NCT06673680 | Recruiting

• 1 other identifier: colposcopy in cancer cervix
• Study Type: observational
• Target: 53
• Locations: 1 country
• Sites: 1

Brief Summary

do colposcopy and cervical punch biopsy then compare between findings

Conditions

Cancer Cervix

Keywords

screening in cancer cervix

Outcome Measures

Primary Outcomes (1)

• comparison between colposcopic findings of suspicious cervix and histopathologic findings

  Correlate colposcopy and histopathological findings in early screening of suspicious cervix and cervical cancer. And to do a colposcopic evaluation of all cervical lesions and the early detection of all cervical precancer and invasive lesions of the cervix in symptomatic women.

  baseline

Study Arms (1)

colposcopic evaluation

do colposcopy and cervical punch biopsy then compare between findings

Device: Do colposcopy and cervical punch biopsy then compare between findings

Interventions

Do colposcopy and cervical punch biopsy then compare between findings DEVICE

The aim of this study is to correlate colposcopy and histopathological findings in early screening of suspicious cervix and cervical cancer. And to do a colposcopic evaluation of all cervical lesions and the early detection of all cervical precancer and invasive lesions of the cervix in symptomatic women.

colposcopic evaluation

Eligibility Criteria

• Age: 18 Years - 60 Years
• Gender Eligibility Details: study use colposcope in screening of cancer cervix
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

* Age from 30 to 64 years old. * Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding. * Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization) * Women with Pap smear showing dysplasia.

You may qualify if:

• Age from 30 to 64 years old.
• Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding.
• Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization)
• Women with Pap smear showing dysplasia

You may not qualify if:

• Pregnant women
• Women having active vaginal bleeding.
• Any past treatment for cervical lesions.
• Women having frank growth of cervix.
• Women who underwent a hysterectomy.

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Sohag university Hospital

Sohag, Egypt

RECRUITING

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Uterine Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Uterine Cervical Diseases; Uterine Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases

Study Officials

• Hazem A prof, MD

  Sohag university hospitals

  STUDY DIRECTOR

Central Study Contacts

Omar K Mohamed, master

CONTACT

+201022827251; kamalo.omar@gmail.com

Mohamed K engineer, Master

CONTACT

+201027836607; kamalo.omar@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident

Study Record Dates

• First Submitted: October 23, 2024
• First Posted: November 5, 2024
• Study Start: October 1, 2024
• Primary Completion: February 28, 2025
• Study Completion: May 30, 2025
• Last Updated: November 5, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)